Table 2. Cohort characteristics.

	Total cohort N = 1029
Sex
Female, n (%)	453 (44.0)
Male, n (%)	576 (56.0)
Age in years, Mean (SD)	67.4 (9.3)
White or Caucasian, n (%)	1002 (97.4)
Disease duration in years, Mean (SD)	4.6 (5.3)
PD Medications
Taking PD medications, n (%)	908 (90.8)
Levodopa, n (%)	789 (76.7)
Dopamine agonist, n (%)	258 (25.1)
Levodopa and dopamine agonist, n (%)	185 (18.0)
Other PD medication, n (%)	337 (32.8)
PFS score, Mean (SD)	48.8 (16.2)
MDS-UPDRS II score, Mean (SD)	11.6 (8.0)
GDS-15 score, Mean (SD)	4.2 (3.7)
SCOPA-NS, Mean (SD)	6.14 (3.59)
SCOPA-DS, Mean (SD)	4.07 (3.27)
PASE score, Mean (SD)	141.6 (87.8)